Comparison
46 Xx Disorder Of Sex Development Induced By Maternal Derived Androgen C5680197 vs 45 X 46 Xy Mixed Gonadal Dysgenesis Cn279762
Clinical comparison between 46 XX Disorder OF Sex Development Induced BY Maternal Derived Androgen and 45 X 46 XY Mixed Gonadal Dysgenesis CN279762 for differential diagnosis and treatment planning.
46 Xx Disorder Of Sex Development Induced By Maternal Derived Androgen C5680197
A condition where androgens from the pregnant person cross to the fetus, causing atypical genital development in an XX baby. It ranges from mild to severe. Specialists guide hormone and surgical management.
45 X 46 Xy Mixed Gonadal Dysgenesis Cn279762
A chromosomal variation affecting sexual development. Involves differences in gonadal tissue and may affect physical development. Care involves hormonal support and multidisciplinary management.
6 comparison axes
Onset
46 Xx Disorder Of Sex Development Induced By Maternal Derived Androgen C5680197
0-0
45 X 46 Xy Mixed Gonadal Dysgenesis Cn279762
0-0
Onset patterns differ
Severity
46 Xx Disorder Of Sex Development Induced By Maternal Derived Androgen C5680197
severe
45 X 46 Xy Mixed Gonadal Dysgenesis Cn279762
moderate
Different severity levels
Chronic
46 Xx Disorder Of Sex Development Induced By Maternal Derived Androgen C5680197
Chronic
45 X 46 Xy Mixed Gonadal Dysgenesis Cn279762
Chronic
Differing course
Communicable
46 Xx Disorder Of Sex Development Induced By Maternal Derived Androgen C5680197
No
45 X 46 Xy Mixed Gonadal Dysgenesis Cn279762
No
Different transmission
Body System
46 Xx Disorder Of Sex Development Induced By Maternal Derived Androgen C5680197
reproductive
45 X 46 Xy Mixed Gonadal Dysgenesis Cn279762
reproductive
Same/different system
Category
46 Xx Disorder Of Sex Development Induced By Maternal Derived Androgen C5680197
endocrine
45 X 46 Xy Mixed Gonadal Dysgenesis Cn279762
genetic
Different category
Bottom line
46-xx-disorder-of-sex-development-induced-by-maternal-derived-androgen-C5680197 and 45-x-46-xy-mixed-gonadal-dysgenesis-CN279762 differ in severity, etiology
Key differentiating points
Findings that most reliably separate the two conditions at the bedside or in the workup.
| Feature | 46 Xx Disorder Of Sex Development Induced By Maternal Derived Androgen C5680197 | 45 X 46 Xy Mixed Gonadal Dysgenesis Cn279762 | Discriminating power |
|---|---|---|---|
| Genital appearance | XX infant may have virilized external genitalia from prenatal androgen exposure. | External genitalia may be atypical, ambiguous, or more typically male or female. | Moderate |
| Gonadal findings | Ovaries are generally expected; gonadal dysgenesis is not the defining feature. | Asymmetric or dysgenetic gonads, including streak and testicular tissue, may occur. | High |
| Associated growth features | Growth or Turner-like features are not established by the supplied description. | Physical development may be affected, but specific features are not established here. | Low |
When to favor each condition
Choose 46 Xx Disorder Of Sex Development Induced By Maternal Derived Androgen C5680197 when
Confirmed 46,XX karyotype with prenatal androgen exposure
The mechanism is maternal-derived androgen acting on an XX fetus.
High
No mosaicism is identified
A normal XX karyotype argues against 45,X/46,XY mosaicism.
Moderate
Virilization without dysgenetic gonads
This pattern fits androgen exposure better than mixed gonadal dysgenesis.
Moderate
Choose 45 X 46 Xy Mixed Gonadal Dysgenesis Cn279762 when
Karyotype shows 45,X and 46,XY cell lines
Mosaicism is the defining evidence for this diagnosis.
High
Asymmetric or streak gonadal tissue is found
Dysgenetic gonads support mixed gonadal dysgenesis when correlated clinically.
Moderate
Chromosomal variation explains development
The supplied category is genetic rather than exogenous androgen exposure.
Moderate
How key tests differ
| Test | 46 Xx Disorder Of Sex Development Induced By Maternal Derived Androgen C5680197 | 45 X 46 Xy Mixed Gonadal Dysgenesis Cn279762 | Interpretation |
|---|---|---|---|
| Karyotype | 46,XX without the defining mosaic lines. | 45,X/46,XY mosaicism. | Karyotype is the main discriminator; clinician review is required. |
| Gonadal imaging or histology | Ovarian tissue may be present; exact findings vary. | Streak, testicular, or asymmetric gonadal tissue may be present. | Results must be interpreted with karyotype and clinical findings. |
| Androgen-source evaluation | Maternal androgen source is relevant during pregnancy. | A maternal androgen source is not the defining cause. | Do not treat an abnormal hormone result as a diagnosis by itself. |
Prognosis comparison
46 Xx Disorder Of Sex Development Induced By Maternal Derived Androgen C5680197
- Outcome
- Variable, from mild to severe atypical development.
- Factors
- Degree of androgen exposure and available specialist care.
45 X 46 Xy Mixed Gonadal Dysgenesis Cn279762
- Outcome
- Variable physical and gonadal development; described severity is moderate.
- Factors
- Mosaic pattern, gonadal function, and associated findings.
Time frame: Often recognized around birth, with lifelong follow-up possible.
Exact prognosis is not established from the supplied data.
Complications comparison
| Complication | Presentation |
|---|---|
| Gonadal tumor concern | Tumor risk is not established by the supplied data. Dysgenetic gonads may warrant surveillance; exact risk is not established here. Decisions require specialist assessment. |
| Hormone deficiency | Hormone needs vary and are not universally established. Hormonal support may be needed, depending on gonadal function. No dose or cutoff is specified. |
| Fertility limitation | Fertility impact is variable and not established here. Gonadal dysgenesis may affect fertility, but outcomes vary. Counseling should be individualized. |
Patient education highlights
- HighDiagnosis
These are different conditions; karyotype and specialist review distinguish them.
- HighCare team
Endocrine, genetics, urology or gynecology, and psychosocial support may be involved.
- MediumDecisions
Hormone or surgical choices are individualized; no single pathway is established here.